Similar articles

Abstract: This study evaluated the effect of a Staphylococcus aureus bacterin and nisin on bovine subclinical mastitis. A total of 75 Holstein subclinically mastitic cows were randomly allocated to three groups with 25 cows per group. In group I, an intramammary infusion of nisin Z at a dose of 2.50×10⁶ IU was carried out once daily for three days, and an autogenous S. aureus bacterin was inoculated into the supramammary lymph node one week before and one week after nisin treatment. In group II, nisin was administered in the same way as in group I, but no bacterin was inoculated. Group III received no treatment and served as a control. Milk was aseptically sampled from the affected quarters before and 2, 4, and 6 weeks after treatment, for bacteriological examination and analyses of N-acetyl-β-D-glucosaminidase (NAGase) activity, somatic cell count (SCC), and milk protein and fat contents. Results indicated that, compared to the nisin-treated group, nisin-bacterin treatment significantly reduced intramammary S. aureus infections, reduced the number of quarters with milk SCCs of more than 5×10⁵ cells/ml, and increased the protein and fat contents of the milk. Therefore, nisin-bacterin therapy is suggested when subclinical mastitis occurs in lactating cows.

疫苗接种与乳酸链球菌素Z治疗对泌乳期奶牛乳腺感染金黄色葡萄球菌的疗效研究

[1]Cao, L.T., Wu, J.Q., Xie, F., et al., 2007. Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J. Dairy Sci., 90(8):3980-3985.

[2]Carr, F.J., Chill, D., Maida, N., 2002. The lactic acid bacteria: a literature survey. Crit. Rev. Microbiol., 28(4):281-370.

[3]Czernomysy-Furowicz, D., Fijalkowski, K., Silecka, A., et al., 2014. Herd-specific autovaccine and antibiotic treatment in elimination of Staphylococcus aureus mastitis in dairy cattle. Turk. J. Vet. Anim. Sci., 38:496-500.

[4]Deegan, L.H., Cotter, P.D., Hill, C., et al., 2006. Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int. Dairy J., 16(9):1058-1071.

[5]Fox, L.K., Hancock, D.D., 1989. Effect of segregation on prevention of intramammary infections by Staphylococcus aureus. J. Dairy Sci., 72(2):540-544.

[6]Fox, L.K., Shook, G.E., Schultz, L.H., 1985. Factors related to milk loss in quarters with low somatic cell counts. J. Dairy Sci., 68(8):2100-2107.

[7]González-RodríGuez, M.C., Gonzalo, C., San Primitivo, F., et al., 1995. Relationship between somatic cell count and intramammary infection of the half udder in dairy ewes. J. Dairy Sci., 78(12):2753-2759.

[8]Luby, C.D., Middleton, J.R., Ma, J., et al., 2007. Characterization of the antibody isotype response in serum and milk of heifers vaccinated with a Staphylococcus aureus bacterin (Lysigin™). J. Dairy Res., 74(2):239-246.

[9]Nordhaug, M.L., Nesse, L.L., Norcross, N.L., et al., 1994. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 2. Antibody response. J. Dairy Sci., 77(5):1276-1284.

[10]Ogola, H., Shitandi, A., Nanua, J., 2007. Effect of mastitis on raw milk compositional quality. J. Vet. Sci., 8(3):237-242.

[11]Pellegrino, M., Giraudo, J., Raspanti, C., et al., 2008. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis. Vet. Microbiol., 127(1-2):186-190.

[12]Smith, G.W., Lyman, R.L., Anderson, K.L., 2006. Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle. J. Am. Vet. Med. Assoc., 228(3):422-425.

[13]Sordillo, L.M., Shafer-Weaver, K., DeRosa, D., 1997. Immunobiology of the mammary gland. J. Dairy Sci., 80(8):1851-1865.

[14]Steele, N., McDougall, S., 2014. Effect of prolonged duration therapy of subclinical mastitis in lactating dairy cows using penethamate hydriodide. New Zeal. Vet. J., 62(1): 38-46.

[15]Tenhagen, B.A., Köster, G., Wallmann, J., et al., 2006. Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J. Dairy Sci., 89(7):2542-2551.

[16]Tong, Z.C., Ni, L.X., Ling, J.Q., 2014. Antibacterial peptide nisin: a potential role in the inhibition of oral pathogenic bacteria. Peptides, 60:32-40.

[17]Tuchscherr, L., Medina, E., Hussain, M., et al., 2011. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol. Med., 3(3): 129-141.

[18]Wu, J.Q., Hu, S.H., Cao, L.T., 2007. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob. Agents Chemother., 51(9):3131-3135.